Modafresh
$ 18,00 – $ 312,00Price range: $ 18,00 through $ 312,00
Modalert
$ 47,00 – $ 301,00Price range: $ 47,00 through $ 301,00
Modaheal
$ 47,00 – $ 375,00Price range: $ 47,00 through $ 375,00
Modaheal is a premium wakefulness-promoting medication specifically formulated to help individuals overcome excessive daytime sleepiness. It provides reliable support for those managing chronic conditions such as narcolepsy and obstructive sleep apnea. This effective treatment is also widely utilized by professionals to maintain peak alertness during irregular shifts or demanding night work. By focusing on the brain’s natural wakefulness centers, it significantly enhances mental clarity and concentration throughout the day. Choosing Modaheal ensures a more productive routine by keeping the mind sharp and reducing the constant urge to rest.
Active substance: Modafinil
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Modaheal (active ingredient: modafinil) belongs to a class of central nervous system medications known as wakefulness-promoting agents. It is a prescription-only medication indicated to improve wakefulness in adult patients who suffer from excessive daytime sleepiness associated with specific diagnosed sleep disorders. In accordance with FDA regulations and federal law, modafinil is classified as a controlled substance and must be dispensed strictly under medical supervision.
While Modaheal helps reduce extreme sleepiness, it does not cure underlying sleep disorders or replace adequate natural sleep. Prescribing decisions depend on a thorough clinical evaluation of the patient’s medical history, current health status, and concurrent medications.
| Drug name | Modaheal |
| Active ingredient | Modafinil |
| Therapeutic class | Central nervous system agent / Wakefulness-promoting agent |
| Dosage form | Oral tablet |
| Route of administration | Oral |
| Prescription status | Prescription (Rx) / Federal Controlled Substance |
| Primary purpose | Improve wakefulness in excessive daytime sleepiness |
How the drug works
execution mechanism: Modaheal operates primarily by increasing wakefulness in the brain, though its precise mechanism of action remains fully uncharacterized. Studies show that modafinil binds to the dopamine transporter and inhibits dopamine reuptake, resulting in an increase in extracellular dopamine concentrations in specific brain regions. Unlike classic sympathomimetic central nervous system stimulants such as amphetamines or methylphenidate, modafinil demonstrates distinct pharmacological properties with lower potential for widespread peripheral nervous system activation.
Additionally, research indicates that modafinil interacts with other neurotransmitter systems, including orexin/hypocretin, histamine, gamma-aminobutyric acid (GABA), and glutamate pathways. This targeted activity in the hypothalamus and related wake-promoting circuits contributes to heightened alertness without inducing generalized central nervous system excitation or rebound hypersomnia under standard therapeutic protocols.
Main uses
Modaheal is indicated by the FDA for the treatment of excessive daytime sleepiness associated with three main medical conditions in adult patients:
- Narcolepsy: To improve daytime wakefulness in patients diagnosed with chronic neurological narcolepsy.
- Obstructive Sleep Apnea (OSA): As an adjunctive treatment to improve wakefulness in patients experiencing residual daytime sleepiness despite consistent treatment with continuous positive airway pressure (CPAP) or other primary OSA therapies.
- Shift Work Disorder (SWD): To treat excessive sleepiness caused by non-traditional work schedules that conflict with natural circadian rhythms.
Off-label notice: Any use of Modaheal for conditions outside of FDA-approved indications–such as attention deficit hyperactivity disorder (ADHD), fatigue related to multiple sclerosis or clinical depression, or cognitive enhancement–is considered off-label. Off-label prescribing must be evaluated independently by a licensed healthcare provider based on individual patient risks and clinical evidence.
Dosing schedule
The standard dosage and administration schedule for Modaheal depends on the specific condition being treated and individual clinical response:
- For Narcolepsy and Obstructive Sleep Apnea: The recommended standard dose is 200 mg taken orally once daily as a single dose in the morning. Taking the medication later in the day is generally avoided to prevent nocturnal sleep disruption.
- For Shift Work Disorder: The typical dose is 200 mg taken orally approximately one hour prior to the start of the work shift.
In elderly patients or individuals with severe hepatic impairment, dosage adjustments are required. For instance, in patients with severe liver dysfunction, the recommended dose is reduced to 50% of the standard adult dosage. The exact dose and treatment duration must be individualised and monitored by the prescribing physician.
Adverse reactions
Modaheal may cause unwanted effects, ranging from mild side effects to severe adverse events. Clinical trial data indicate that the most common side effects reported by patients include:
- Headache (reported as the most frequent side effect)
- Nausea and gastrointestinal discomfort
- Nervousness, anxiety, and insomnia
- Rhinitis and nasal congestion
- Dizziness and dry mouth
Less common but severe adverse reactions require medical evaluation. These include severe dermatologic hypersensitivity reactions, cardiovascular alterations (such as chest pain or hypertension), and significant psychiatric symptoms. Patients should report any new or unexpected symptoms to their physician promptly.
What happens in the body
Modaheal is rapidly absorbed following oral administration, reaching peak plasma concentrations within approximately 2 to 4 hours. Co-administration with food does not alter the overall bioavailability (area under the curve), although it may delay peak absorption by approximately 1 hour. Modafinil is extensively bound to plasma proteins, primarily albumin (approximately 60%). Metabolism occurs predominantly in the liver via hydrolytic cleavage, alkyds oxidation, and cytochrome P450 enzymatic pathways, particularly CYP3A4/5. Elimination half-life ranges from 12 to 15 hours in adults with normal renal and hepatic function. The main metabolic end-products are inactive and excreted primarily through the kidneys.
What not to combine
Modaheal exhibits multiple metabolic drug interaction pathways that require careful review before initiating therapy:
- Hormonal Contraceptives: Modafinil induces CYP3A4 enzymes, which significantly lowers blood concentrations of hormonal contraceptives (including oral pills, patches, implants, and injections). Alternative or secondary non-hormonal contraception must be used during treatment and for one month following discontinuation.
- CYP2C19 Substrates: Modafinil acts as a reversible inhibitor of CYP2C19, potentially increasing systemic exposure to co-administered drugs such as omeprazole, diazepam, phenytoin, and proguanil.
- Warfarin: Co-administration with warfarin may alter prothrombin time/INR. Regular monitoring is recommended when starting or stopping Modaheal.
- Other CNS Agents: Combining Modaheal with central nervous system stimulants, monoamine oxidase inhibitors (MAOIs), or alcohol can increase the risk of adverse cardiovascular or psychiatric events and is generally contraindicated.
Important precautions
Prior to starting Modaheal, healthcare providers must evaluate several critical warnings and precautions:
Severe Cutaneous Adverse Reactions: Modafinil has been associated with rare but life-threatening skin reactions, including Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Drug Rash with Eosinophilia and Systemic Symptoms (DRESS). Modaheal must be discontinued immediately at the first sign of a skin rash or mucosal hypersensitivity reaction.
Psychiatric Symptoms: Caution is warranted in patients with a history of psychosis, depression, or mania. Treatment with modafinil may trigger or exacerbate psychiatric events, including severe anxiety, agitation, hallucinations, mania, and suicidal ideation.
Cardiovascular Conditions: Modaheal is not recommended for patients with a history of left ventricular hypertrophy, ischemic heart disease, mitral valve prolapse syndrome, or recent myocardial infarction. Monitoring of blood pressure and heart rate is recommended throughout therapy.
Pregnancy and Breastfeeding: Limited data exist regarding the safety of modafinil in pregnant women. Animal studies indicate potential fetal harm, and epidemiological registries report an increased risk of major congenital malformations. Modaheal should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Nursing mothers should exercise caution, as it is unknown whether modafinil is excreted in human milk.
Red flags
Patients taking Modaheal must seek emergency medical attention immediately if any of the following serious symptoms occur:
- Signs of serious skin rash, hives, mouth sores, skin peeling, or blistering
- Swelling of the face, lips, tongue, throat, or difficulty swallowing or breathing
- Chest pain, irregular heartbeat, or severe dizziness
- Severe psychiatric changes, including suicidal thoughts, hallucinations, or aggressive behavior
Missed dose
If a dose of Modaheal is missed, it should be taken as soon as remembered if it is still early in the day or early in the work shift. If it is late afternoon or close to bedtime, the missed dose should be skipped entirely to prevent severe insomnia. Patients must never double up on doses to make up for a missed tablet.
Practical tips
For daily management, patients should take Modaheal at a consistent time each morning or one hour prior to a work shift as directed by their physician. Because modafinil may impair judgment, thinking, or motor skills, patients should avoid operating machinery or driving vehicles until they fully understand how the drug affects them personally. Regular monitoring of blood pressure and periodic consultations with a physician are essential for long-term safety.
Storage and expiration
Modaheal tablets should be stored at controlled room temperature between 68°F and 77°F (20°C to 25°C), away from excessive heat, light, and moisture. Store the medication in its original container and keep it out of reach of children and pets. Expired or unused controlled substances must be disposed of safely through drug take-back programs in accordance with federal law and local public health rules.
Common questions
Does Modaheal treat the underlying cause of sleep apnea?
No. Modaheal is used only as an adjunctive therapy to reduce daytime sleepiness caused by obstructive sleep apnea. It does not treat the underlying mechanical airway obstruction. Patients taking Modaheal for OSA must continue using their continuous positive airway pressure (CPAP) machine or other prescribed primary devices as directed by their physician.
Why is non-hormonal contraception required while taking Modaheal?
Modaheal stimulates liver enzymes (specifically CYP3A4) responsible for breaking down synthetic hormones found in birth control pills, patches, implants, and injections. This interaction reduces blood levels of these contraceptives, making them less effective at preventing pregnancy. Secondary non-hormonal methods (such as condoms) must be used during treatment and for one month after stopping the medication.
Can Modaheal cause physical dependence or withdrawal symptoms?
Because modafinil acts on central nervous system dopamine pathways, it carries a potential for abuse and dependence, which is why federal regulations categorize it as a controlled substance. Abrupt cessation after prolonged clinical use generally does not produce severe withdrawal symptoms, but excessive sleepiness and fatigue may return.
Is it safe to consume alcohol while taking Modaheal?
No. The safety of combining modafinil with alcohol has not been established. Consuming alcohol while taking Modaheal can alter central nervous system response, increase the risk of adverse cardiovascular or cognitive side effects, and disrupt normal sleep architecture. Patients are advised to avoid alcohol during treatment.
In accordance with FDA requirements.
This text is for informational purposes only and does not constitute individual medical advice.
Additional information
| Dosage |
100 mg ,200 mg |
|---|---|
| Package |
30 pills ,60 pills ,100 pills ,200 pills ,300 pills ,500 pills |
| Ενεργός Ουσία |
Related products
Actigall
$ 60,00 – $ 521,00Price range: $ 60,00 through $ 521,00
Active substance: Ursodiol
More Details
This product has multiple variants. The options may be chosen on the product page
Cyclosporine
$ 43,00 – $ 216,00Price range: $ 43,00 through $ 216,00
Active substance: Cyclosporine
More Details
This product has multiple variants. The options may be chosen on the product page
Deflazacort
$ 18,00 – $ 170,00Price range: $ 18,00 through $ 170,00
Active substance: Deflazacort
More Details
This product has multiple variants. The options may be chosen on the product page
Esbriet
$ 100,00 – $ 328,00Price range: $ 100,00 through $ 328,00
Active substance: Pirfenidone
More Details
This product has multiple variants. The options may be chosen on the product page
Eurax Lotion
$ 3,00 – $ 15,00Price range: $ 3,00 through $ 15,00
Active substance: Crotamiton
More Details
This product has multiple variants. The options may be chosen on the product page
Imusporin
$ 117,00 – $ 535,00Price range: $ 117,00 through $ 535,00
Active substance: Cyclosporine
More Details
This product has multiple variants. The options may be chosen on the product page
Limcee
$ 21,00 – $ 39,00Price range: $ 21,00 through $ 39,00
Active substance: Ascorbic Acid
More Details
This product has multiple variants. The options may be chosen on the product page
Natrise
$ 45,00 – $ 115,00Price range: $ 45,00 through $ 115,00
Active substance: Tolvaptan
More Details
This product has multiple variants. The options may be chosen on the product page
